Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 1
2009 1
2010 2
2011 1
2012 3
2013 1
2014 1
2015 2
2016 1
2017 2
2018 2
2019 1
2020 3
2021 4
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Leveraging NKG2D Ligands in Immuno-Oncology.
Fuertes MB, Domaica CI, Zwirner NW. Fuertes MB, et al. Among authors: domaica ci. Front Immunol. 2021 Jul 29;12:713158. doi: 10.3389/fimmu.2021.713158. eCollection 2021. Front Immunol. 2021. PMID: 34394116 Free PMC article. Review.
Regulatory functions of NK cells during infections and cancer.
Zwirner NW, Domaica CI, Fuertes MB. Zwirner NW, et al. Among authors: domaica ci. J Leukoc Biol. 2021 Jan;109(1):185-194. doi: 10.1002/JLB.3MR0820-685R. Epub 2020 Oct 23. J Leukoc Biol. 2021. PMID: 33095941 Review.
Immunomodulation of NK Cell Activity.
Domaica CI, Sierra JM, Zwirner NW, Fuertes MB. Domaica CI, et al. Methods Mol Biol. 2020;2097:125-136. doi: 10.1007/978-1-0716-0203-4_9. Methods Mol Biol. 2020. PMID: 31776924
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology.
Secchiari F, Nuñez SY, Sierra JM, Ziblat A, Regge MV, Raffo Iraolagoitia XL, Rovegno A, Ameri C, Secin FP, Richards N, Ríos Pita H, Vitagliano G, Rico L, Mieggi M, Frascheri F, Bonanno N, Blas L, Trotta A, Friedrich AD, Fuertes MB, Domaica CI, Zwirner NW. Secchiari F, et al. Among authors: domaica ci. Oncoimmunology. 2022 Aug 3;11(1):2104991. doi: 10.1080/2162402X.2022.2104991. eCollection 2022. Oncoimmunology. 2022. PMID: 35936986 Free PMC article.
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein.
Torres N, Regge MV, Secchiari F, Friedrich AD, Spallanzani RG, Raffo Iraolagoitia XL, Núñez SY, Sierra JM, Ziblat A, Santilli MC, Gilio N, Almada E, Lauche C, Pardo R, Domaica CI, Fuertes MB, Madauss KP, Hance KW, Gloger IS, Zylberman V, Goldbaum FA, Zwirner NW. Torres N, et al. Among authors: domaica ci. J Immunother Cancer. 2020 Jun;8(1):e000233. doi: 10.1136/jitc-2019-000233. Epub 2020 Jun 8. J Immunother Cancer. 2020. PMID: 32518090 Free PMC article.
Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation.
Sierra JM, Secchiari F, Nuñez SY, Iraolagoitia XLR, Ziblat A, Friedrich AD, Regge MV, Santilli MC, Torres NI, Gantov M, Trotta A, Ameri C, Vitagliano G, Pita HR, Rico L, Rovegno A, Richards N, Domaica CI, Zwirner NW, Fuertes MB. Sierra JM, et al. Among authors: domaica ci. Front Immunol. 2021 Sep 20;12:745939. doi: 10.3389/fimmu.2021.745939. eCollection 2021. Front Immunol. 2021. PMID: 34616407 Free PMC article.
25 results